MAYWOOD, Ill. -- Loyola University Health System is joining the Leukemia Research Foundation and the National Marrow Donor Program in hosting a free conference on Saturday, May 5, for leukemia, lymphoma and myelodysplastic syndromes (MDS) patients and caregivers.
The conference will be held at the Renaissance Schaumburg Convention Center Hotel, 1551 N. Thoreau Drive, Schaumburg, Ill., from 7:30 a.m. to 12:15 p.m. Parking, a continental breakfast and lunch will be provided free of charge.
The Treatment Options for Blood Cancer Patients Conference will provide information on treatments for leukemia, lymphoma and other blood cancers, as well as the perspectives of patients and at-home caregivers.
Dr. Patrick Stiff, director of Loyola's Cardinal Bernardin Cancer Center, developed this patient program with the Leukemia Research Foundation. Stiff will give a talk titled, "When Should Stem Cell Transplantation Be Used to Treat Leukemia and Lymphoma?"
Dr. Tulio Rodriguez, medical director of Loyola's Bone Marrow Transplantation Program, will give a talk titled, "Myeloma: Whom and When to Transplant."
For an agenda and information, and to make reservations, visit www.leukemia-research.org/treatmentoptions or call (847) 424-0600.
About Loyola
Loyola's Bone Marrow Transplantation Program is the largest transplant program in Illinois, and has performed more than 3,000 transplants. Loyola is a participating transplant, apheresis and collection center in the National Marrow Donor Program network.
Transplant options available at Loyola include autologous bone marrow and peripheral blood stem cell, allogeneic related and unrelated bone marrow and allogeneic unrelated umbilical cord blood transplants.
Patients have opportunities to participate in clinical trials, including national breast, lymphoma, leukemia, ovarian, testicular and multiple myeloma studies.
About the Leukemia Research Foundation
The Leukemia Research Foundation, headquartered in Wilmette, Ill., is dedicated to funding research and providing support to people affected by blood cancers.
The foundation’s mission is to conquer leukemia, lymphoma and myelodysplastic syndromes by funding research into their causes and cures, and to enrich the quality of life of those touched by these diseases.
For more than 65 years, thousands of volunteers and 23 chapters have helped the foundation raise more than $52 million to help fund research specifically targeting aspiring, eager and innovative scientists and physicians around the world, provide patient financial assistance, and offer educational and emotional support for patients and their families.